|
|
|
| Best-In-Class Solutions Accelerate Development Of GLP-1 Therapeutics | Article | By Graham C. Ellis, M.D.; Eling Gaines; and Rose Blackburne, M.D., MBA, PPD Clinical Research Business of Thermo Fisher Scientific | As metabolic trials expand, success hinges on mitigating participant fatigue, offering culturally tailored dietary support, and designing inclusive protocols to retain a truly diverse cohort. |
|
|
| Trusted RTSM, Powered By Exceptional People | Video | Endpoint Clinical | Purpose‑driven work, deep experience, and strong values help life‑changing therapies reach patients faster through empathy, collaboration, and quality across life sciences. |
|
|
|
|
| Education Is Essential To Representative Enrollment | Video | Clinical Leader | According to Leida Bowen, the biggest challenge with inclusive trials is often education, helping colleagues and stakeholders better understand patient disparities and experiences so they can avoid unintentionally creating barriers to participation. |
|
|
|
|
|
| Why The Governed Hybrid Site Model Is Strategically Superior — Part 3 | Guest Column | By Kurt Mussina, Paradigm Clinical Research, and Association of Multisite Research Corporations (AMRC) | In the third and final part of this series, Paradigm Clinical Research CEO Kurt Mussina, who's become an advocate for the governed hybrid platform, explains why he believes it's the best fit for sponsors. |
|
|
|
|
|
CHOOSE YOUR OWN ADVENTURE |
|
|
|
| You're receiving the Monday edition of the Clinical Leader newsletter, focusing on Clinical Sites, Patient Centricity, and Patient Recruitment. To make changes to your newsletter selections, update your topic preferences. - Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
- Clinical Trial Technology (Tuesday)
- Decentralized Trials | Trial Management (Wednesday)
- Outsourcing Models | Regulatory & Compliance (Thursday)
- Clinical Data Management & Analytics | Trial Monitoring (Friday)
Learn more about our personalized newsletters here. |
|
|
| Connect With Clinical Leader: |
|
|
|